Long-term results of hypofractionated stereotactic radiotherapy with CyberKnife for growth hormone-secreting pituitary adenoma: evaluation by the Cortina consensus.

MLA

Iwata, Hiromitsu, et al. “Long-Term Results of Hypofractionated Stereotactic Radiotherapy with CyberKnife for Growth Hormone-Secreting Pituitary Adenoma: Evaluation by the Cortina Consensus.” Journal of Neuro-Oncology, vol. 128, no. 2, June 2016, pp. 267–75. EBSCOhost, https://doi.org/10.1007/s11060-016-2105-1.

APA

Iwata, H., Sato, K., Nomura, R., Tabei, Y., Suzuki, I., Yokota, N., Inoue, M., Ohta, S., Yamada, S., & Shibamoto, Y. (2016). Long-term results of hypofractionated stereotactic radiotherapy with CyberKnife for growth hormone-secreting pituitary adenoma: evaluation by the Cortina consensus. Journal of Neuro-Oncology, 128(2), 267–275. https://doi.org/10.1007/s11060-016-2105-1

Chicago

Iwata, Hiromitsu, Kengo Sato, Ryutaro Nomura, Yusuke Tabei, Ichiro Suzuki, Naoki Yokota, Mitsuhiro Inoue, Seiji Ohta, Shozo Yamada, and Yuta Shibamoto. 2016. “Long-Term Results of Hypofractionated Stereotactic Radiotherapy with CyberKnife for Growth Hormone-Secreting Pituitary Adenoma: Evaluation by the Cortina Consensus.” Journal of Neuro-Oncology 128 (2): 267–75. doi:10.1007/s11060-016-2105-1.